Can you take metformin with insulin?

Reviewed 10 sourcesPublished by PepVault

Yes, in type 2 diabetes: the metformin and insulin labels side by side on low blood sugar, what HOME and the type 1 trials measured, and who sets each dose.

Woman in a lilac long-sleeve runs a riverside path at sunrise
Last reviewed
Sources
10
Questions
6
Compounds
1

The short answer

Yes. In type 2 diabetes, metformin is one of the drugs most often taken with insulin, and both labels plan for the pair. Metformin's says the combination can raise the risk of low blood sugar, so a lower insulin dose may be needed; insulin labels ask for dose changes and more glucose checks. In trials, adding metformin cut insulin needs and weight gain. Your prescriber sets both doses.

Every number checked at its primary source · · 10 sources · How we research

Evidence: FDA labels for metformin, Humulin R and Lantus, randomized placebo-controlled trials of metformin added to insulin in type 2 (HOME) and type 1 diabetes (REMOVAL, T1D Exchange), and systematic reviews whose included trials were small and at high risk of bias.

Woman in a lilac long-sleeve runs a riverside path at sunrise

What do the metformin and insulin labels say about taking them together?

Both labels name the pairing, and they say the same thing from opposite ends. Metformin's warning section reads: "Metformin hydrochloride may increase the risk of hypoglycemia when combined with insulin and/or an insulin secretagogue," so "a lower dose of insulin or insulin secretagogue may be required"1. Hypoglycemia is low blood sugar; an insulin secretagogue is a pill such as a sulfonylurea that pushes the pancreas to release insulin. The insulin labels list "antidiabetic agents" among the drugs that may raise the risk of lows, and ask for dose changes and more frequent glucose checks when they are combined23.

LabelWhat it says about the pairWhat it asks for
Metformin tablets1Combined with insulin, may increase the risk of hypoglycemia; metformin on its own rarely causes itA lower insulin dose may be needed; patients taught the symptoms and treatment of lows
Humulin R, a mealtime human insulin2Antidiabetic agents may increase the risk of hypoglycemia; lows are the most common side effect of all insulinsDose adjustment and more frequent glucose monitoring; in type 2 diabetes, other diabetes drugs may need adjusting
Lantus, a long-acting insulin glargine3Antidiabetic agents may increase the risk of hypoglycemiaDose reductions and more frequent glucose monitoring may be required

Neither label treats the pair as one to avoid. Lantus was tested for 52 weeks in 570 adults with type 2 diabetes who stayed on their pills, metformin among them3. Metformin's medication guide simply asks you to tell your provider if you "are taking insulin"1. What the labels leave to the prescriber is the numbers: which dose comes down, by how much, and how often you check.

PepVault holds metformin as a twice-daily tablet with its own reminders, so each dose shows on Today next to the rest of your plan. Set reminders in PepVault

A smiling woman in a blue top leaning on her kitchen counter with her phone and a notebook

PepVault for iPhone

Keep your protocol in PepVault

PepVault holds metformin as a twice-daily tablet with its own reminders, so each dose shows on Today next to the rest of your plan.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Is metformin insulin?

No. Metformin is a biguanide, a tablet that lowers blood sugar without adding insulin or squeezing more out of the pancreas. Its label lists three actions: the liver releases less sugar, the gut absorbs a little less, and muscle takes up more sugar in response to the insulin already there. "Insulin secretion remains unchanged," the label says, and the medication guide puts it plainly: metformin does "not cause your body to make more insulin" and "rarely" causes low blood sugar by itself1.

Insulin is the hormone itself. An injection supplies it from outside, and it keeps lowering blood sugar whatever the level, which is why low blood sugar is "the most common adverse reaction of all insulins"2. So the two meet in the middle: insulin brings the hormone, metformin helps the body need less of it. That is the whole logic of the pair. Our guide on whether Ozempic is insulin covers the third kind, the GLP-1 drugs, and our insulin resistance guide covers the tests behind "helps the body respond".

Did any study combine metformin and insulin?

Many did, and the biggest is HOME, a Dutch trial that added metformin 850 mg or a placebo, one to three times a day, to insulin in 390 people with type 2 diabetes and followed them for 4.3 years45. The insulin was adjusted to strict targets in both groups, so the question was what metformin changed on top. HbA1c is the blood test for average sugar over about three months.

TrialPeopleInsulin doseWeightHbA1c
HOME, 16 weeks4390 adults with type 2 diabetes on insulin63.8 vs 71.3 units a day on placebo-0.4 vs +1.2 kg6.9% vs 7.6%
HOME, 4.3 years5The same 39019.6 units a day lower than placebo3.07 kg less gain0.4 points lower
Avilés-Santa, 24 weeks643 adults with type 2 diabetes poorly controlled on insulinRose 22.8 units more on placebo; fell slightly on metformin+0.5 vs +3.2 kgFell 2.5 vs 1.6 points; 6.5% vs 7.6% at the end
Review of 23 trials72,117 adults with type 2 diabetesAbout 5 units a day lowerAbout 1 kg less gainAbout 0.5 points lower

The pattern holds across them: metformin brings equal or better sugar control with less insulin and less of the weight gain insulin brings. HOME's main goal, a combined count of small-vessel and large-vessel disease and death, did not improve; its large-vessel count alone, a secondary goal, fell (hazard ratio 0.61), partly explained by the weight difference5. The 2012 review of all the randomized trials found no difference in deaths either way and judged every trial at high risk of bias7. The HOME authors' own conclusion was to keep metformin going when insulin starts, unless something rules it out5.

Can you take metformin with insulin in type 1 diabetes?

Not on the label. Metformin is approved for type 2 diabetes, and its medication guide says it "should not be used to treat people with type 1 diabetes"1. Doctors do add it to insulin off-label, mostly to trim insulin doses and weight, and three sets of trials measured what that does.

StudyPeopleWhat it found
REMOVAL, 3 years8428 adults 40 or older with type 1 diabetes and heart risk factors; metformin 1,000 mg twice a day or placeboMain goal, artery wall thickening, not significantly slowed; HbA1c down 0.24 points at 3 months but not after; weight -1.17 kg; LDL cholesterol lower; insulin dose not lower on average; no rise in lows
T1D Exchange, 26 weeks9140 overweight teenagers with type 1 diabetes; up to 2,000 mg a day or placeboHbA1c no different at 26 weeks; insulin per kg cut by a quarter or more in 23% vs 1%; more stomach side effects
Review of 9 trials10People with type 1 diabetes, of varied ages and trial lengthsInsulin 6.6 units a day lower in the five trials that could be pooled; HbA1c not significantly lower; a trend towards more lows

Read together: in type 1 diabetes metformin trims weight and, in shorter trials, insulin dose, but it does not hold down HbA1c, and the stomach is the price. In REMOVAL 27% stopped metformin against 12% on placebo, mainly for gut side effects8. REMOVAL's authors concluded that the data do not support metformin for sugar control in long-standing type 1 diabetes, while leaving a possible role in heart risk open8.

Will metformin with insulin drop your blood sugar too low?

The label says it can; the biggest single trials found little or no extra risk. In HOME's first 16 weeks the risk of lows was similar with metformin and placebo4, and REMOVAL saw no increase8. The 2012 review found severe lows more often with the pair in one way of pooling the trials but not in the other7, and the type 1 review saw a trend10. The steady finding is that the risk sits mostly with the insulin, and the labels' answer is the same either way: adjust the insulin, check more often12.

The insulin label lists the signs: dizziness or lightheadedness, sweating, confusion, headache, blurred vision, slurred speech, shakiness, a fast heartbeat, anxiety, irritability or mood changes, and hunger. Mild lows are usually treated with sugar by mouth, and a prescriber may give you a glucagon product that someone else can inject if you cannot take sugar by mouth2. Metformin's guide adds that lows are more likely if you do not eat enough or drink alcohol1; our metformin and alcohol guide covers that part.

Commonly reported: lower readings in the first weeks after metformin joins insulin, an insulin dose that comes down a few units with the prescriber, and loose stools in the first weeks that usually settle as the body adjusts.

When to get help Repeated lows after metformin joins insulin are a reason to call your prescriber soon; a low with fainting, a seizure or too much confusion to swallow, or one that sugar by mouth does not lift, needs emergency help2.

What should you tell your prescriber when metformin and insulin are combined?

  1. Tell the prescriber of each drug that you take the other; both labels expect the insulin dose may need to change when they are combined12.
  2. Check your blood sugar as your prescriber asks, and expect to check more often in the first weeks; the insulin labels call for more frequent monitoring23.
  3. Ask how to recognise and treat a low, and whether you should carry a glucagon product12.
  4. Ask what to do with both drugs on a sick day or before surgery; the metformin guide says the amount of diabetes medicine you need may change under stress such as fever, infection or surgery, and that metformin is stopped for a short time before an x-ray with contrast dye, or before surgery when you cannot eat or drink much1. Metformin's label carries a boxed warning for lactic acidosis, a rare but serious build-up of acid in the blood; kidney problems, contrast dye, surgery, heavy drinking and age 65 or over raise the risk1.
  5. Keep the kidney blood test (eGFR) metformin's label asks for at least once a year1.

PepVault's log keeps each dose you took and the side effects you noted by day, so a run of lows or loose stools is easy to show your prescriber. Log it in PepVault

Starting metformin slowly and with meals is the label's way of keeping the stomach calm; our metformin with food guide has the details. If metformin is being added to a GLP-1 drug rather than insulin, our metformin with a GLP-1 guide has those labels side by side.

Track it in the app

Sources

  1. Metformin hydrochloride tablets, prescribing information and medication guide, sections 1, 2.3, 5.3, 7, 12.1 and 17. PD-Rx Pharmaceuticals. DailyMed SPL version 20, Nov 2026. dailymed.nlm.nih.gov
  2. Humulin R (insulin human) injection, prescribing information and patient information, sections 5.2, 5.3, 7 and 10. Eli Lilly. DailyMed SPL version 35, Sep 2026. dailymed.nlm.nih.gov
  3. Lantus (insulin glargine) injection, prescribing information, sections 5.2, 5.3, 7 and 14. Sanofi-Aventis. DailyMed SPL version 35, Jul 2025. dailymed.nlm.nih.gov
  4. Wulffelé MG et al. Combination of insulin and metformin in the treatment of type 2 diabetes (HOME, 16-week analysis). Diabetes Care. 2002. PubMed 12453950
  5. Kooy A et al. Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus (HOME). Arch Intern Med. 2009. PubMed 19307526
  6. Avilés-Santa L, Sinding J, Raskin P. Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. Ann Intern Med. 1999. PubMed 10428734
  7. Hemmingsen B et al. Comparison of metformin and insulin versus insulin alone for type 2 diabetes: systematic review of randomised clinical trials with meta-analyses and trial sequential analyses. BMJ. 2012. PubMed 22517929
  8. Petrie JR et al. Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 2017. PubMed 28615149
  9. Libman IM et al. Effect of metformin added to insulin on glycemic control among overweight/obese adolescents with type 1 diabetes: a randomized clinical trial. JAMA. 2015. PubMed 26624824
  10. Vella S et al. The use of metformin in type 1 diabetes: a systematic review of efficacy. Diabetologia. 2010. PubMed 20057994

Newsletter · Weekly

The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

We’ll email you a link to confirm. Your address is used for the briefing only. Privacy

PepVault for iPhone

Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo